154 related articles for article (PubMed ID: 29367704)
21. Leptin Decreases Energy Expenditure Despite Increased Thyroid Hormone in Patients With Lipodystrophy.
Grover A; Quaye E; Brychta RJ; Christensen J; Startzell MS; Meehan CA; Valencia A; Marshall B; Chen KY; Brown RJ
J Clin Endocrinol Metab; 2021 Sep; 106(10):e4163-e4178. PubMed ID: 33890058
[TBL] [Abstract][Full Text] [Related]
22. Seipin ablation in mice results in severe generalized lipodystrophy.
Cui X; Wang Y; Tang Y; Liu Y; Zhao L; Deng J; Xu G; Peng X; Ju S; Liu G; Yang H
Hum Mol Genet; 2011 Aug; 20(15):3022-30. PubMed ID: 21551454
[TBL] [Abstract][Full Text] [Related]
23. Metreleptin Treatment in Patients with Non-HIV Associated Lipodystrophy.
Akinci G; Akinci B
Recent Pat Endocr Metab Immune Drug Discov; 2015; 9(2):74-8. PubMed ID: 26556498
[TBL] [Abstract][Full Text] [Related]
24. A Report of Three Cases With Acquired Generalized Lipodystrophy With Distinct Autoimmune Conditions Treated With Metreleptin.
Lebastchi J; Ajluni N; Neidert A; Oral EA
J Clin Endocrinol Metab; 2015 Nov; 100(11):3967-70. PubMed ID: 26390101
[TBL] [Abstract][Full Text] [Related]
25. Effect of Leptin Therapy on Survival in Generalized and Partial Lipodystrophy: A Matched Cohort Analysis.
Cook K; Ali O; Akinci B; Foss de Freitas MC; Montenegro RM; Fernandes VO; Gupta D; Lou KJ; Tuttle E; Oral EA; Brown RJ
J Clin Endocrinol Metab; 2021 Jul; 106(8):e2953-e2967. PubMed ID: 33822100
[TBL] [Abstract][Full Text] [Related]
26. Rationale for leptin-replacement therapy for severe lipodystrophy.
Oral EA; Chan JL
Endocr Pract; 2010; 16(2):324-33. PubMed ID: 20061299
[TBL] [Abstract][Full Text] [Related]
27. Therapeutic indications and metabolic effects of metreleptin in patients with lipodystrophy syndromes: Real-life experience from a national reference network.
Mosbah H; Vantyghem MC; Nobécourt E; Andreelli F; Archambeaud F; Bismuth E; Briet C; Cartigny M; Chevalier B; Donadille B; Daguenel A; Fichet M; Gautier JF; Janmaat S; Jéru I; Legagneur C; Leguier L; Maitre J; Mongeois E; Poitou C; Renard E; Reznik Y; Spiteri A; Travert F; Vergès B; Zammouri J; Vigouroux C; Vatier C
Diabetes Obes Metab; 2022 Aug; 24(8):1565-1577. PubMed ID: 35445532
[TBL] [Abstract][Full Text] [Related]
28. Lymphoma in acquired generalized lipodystrophy.
Brown RJ; Chan JL; Jaffe ES; Cochran E; DePaoli AM; Gautier JF; Goujard C; Vigouroux C; Gorden P
Leuk Lymphoma; 2016; 57(1):45-50. PubMed ID: 25864863
[TBL] [Abstract][Full Text] [Related]
29. Facial soft tissue volume decreases during metreleptin treatment in patients with partial and generalized lipodystrophy.
Miehle K; Stumvoll M; Fasshauer M; Hierl T
Endocrine; 2017 Nov; 58(2):262-266. PubMed ID: 28993984
[TBL] [Abstract][Full Text] [Related]
30. Metreleptin: first global approval.
Chou K; Perry CM
Drugs; 2013 Jun; 73(9):989-97. PubMed ID: 23740412
[TBL] [Abstract][Full Text] [Related]
31. Suggestive Evidence for an Antidepressant Effect of Metreleptin Treatment in Patients with Lipodystrophy.
Vieira DB; Antel J; Peters T; Miehle K; Stumvoll M; Hebebrand J; Schlögl H
Obes Facts; 2022; 15(5):685-693. PubMed ID: 36037795
[TBL] [Abstract][Full Text] [Related]
32. Leptin Substitution in Patients With Lipodystrophy: Neural Correlates for Long-term Success in the Normalization of Eating Behavior.
Schlögl H; Müller K; Horstmann A; Miehle K; Püschel J; Villringer A; Pleger B; Stumvoll M; Fasshauer M
Diabetes; 2016 Aug; 65(8):2179-86. PubMed ID: 27207511
[TBL] [Abstract][Full Text] [Related]
33. Seipin deficiency alters fatty acid Delta9 desaturation and lipid droplet formation in Berardinelli-Seip congenital lipodystrophy.
Boutet E; El Mourabit H; Prot M; Nemani M; Khallouf E; Colard O; Maurice M; Durand-Schneider AM; Chrétien Y; Grès S; Wolf C; Saulnier-Blache JS; Capeau J; Magré J
Biochimie; 2009 Jun; 91(6):796-803. PubMed ID: 19278620
[TBL] [Abstract][Full Text] [Related]
34. Recombinant human leptin treatment in genetic lipodystrophic syndromes: the long-term Spanish experience.
Araujo-Vilar D; Sánchez-Iglesias S; Guillín-Amarelle C; Castro A; Lage M; Pazos M; Rial JM; Blasco J; Guillén-Navarro E; Domingo-Jiménez R; del Campo MR; González-Méndez B; Casanueva FF
Endocrine; 2015 May; 49(1):139-47. PubMed ID: 25367549
[TBL] [Abstract][Full Text] [Related]
35. Endogenous Leptin Concentrations Poorly Predict Metreleptin Response in Patients With Partial Lipodystrophy.
Meral R; Malandrino N; Walter M; Neidert AH; Muniyappa R; Oral EA; Brown RJ
J Clin Endocrinol Metab; 2022 Mar; 107(4):e1739-e1751. PubMed ID: 34677608
[TBL] [Abstract][Full Text] [Related]
36. Overexpression of a short human seipin/BSCL2 isoform in mouse adipose tissue results in mild lipodystrophy.
Cui X; Wang Y; Meng L; Fei W; Deng J; Xu G; Peng X; Ju S; Zhang L; Liu G; Zhao L; Yang H
Am J Physiol Endocrinol Metab; 2012 Mar; 302(6):E705-13. PubMed ID: 22234369
[TBL] [Abstract][Full Text] [Related]
37. Beneficial effects of leptin substitution on impaired eating behavior in lipodystrophy are sustained beyond 150 weeks of treatment.
Püschel J; Miehle K; Müller K; Villringer A; Stumvoll M; Fasshauer M; Schlögl H
Cytokine; 2019 Jan; 113():400-404. PubMed ID: 30539782
[TBL] [Abstract][Full Text] [Related]
38. Impaired adipogenic capacity in induced pluripotent stem cells from lipodystrophic patients with BSCL2 mutations.
Mori E; Fujikura J; Noguchi M; Nakao K; Matsubara M; Sone M; Taura D; Kusakabe T; Ebihara K; Tanaka T; Hosoda K; Takahashi K; Asaka I; Inagaki N; Nakao K
Metabolism; 2016 Apr; 65(4):543-56. PubMed ID: 26975546
[TBL] [Abstract][Full Text] [Related]
39. Alleviation of seipinopathy-related ER stress by triglyceride storage.
Hölttä-Vuori M; Salo VT; Ohsaki Y; Suster ML; Ikonen E
Hum Mol Genet; 2013 Mar; 22(6):1157-66. PubMed ID: 23250914
[TBL] [Abstract][Full Text] [Related]
40. Higher adiponectin levels in patients with Berardinelli-Seip congenital lipodystrophy due to seipin as compared with 1-acylglycerol-3-phosphate-o-acyltransferase-2 deficiency.
Antuna-Puente B; Boutet E; Vigouroux C; Lascols O; Slama L; Caron-Debarle M; Khallouf E; Lévy-Marchal C; Capeau J; Bastard JP; Magré J
J Clin Endocrinol Metab; 2010 Mar; 95(3):1463-8. PubMed ID: 20097706
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
